June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Use of Generative Adversarial Network to Improve Glaucoma Gradability of Fundus Images
Author Affiliations & Notes
  • Justin Huynh
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
    Department of Computer Science and Engineering,, University of California San Diego, La Jolla, California, United States
  • Benton Gabriel Chuter
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Mark Christopher
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Christopher Bowd
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Rui Fan
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
    College of Electronics and Information Engineering, Tongji University, Shanghai, Shanghai, China
  • Michael Henry Goldbaum
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Akram Belghith
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Christopher A Girkin
    Department of Ophthalmology, School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Massimo A. Fazio
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
    Department of Ophthalmology, School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Carlos G DeMoraes
    Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, United States
  • Jeffrey M Liebmann
    Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, United States
  • Robert N Weinreb
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Linda Zangwill
    Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Justin Huynh None; Benton Chuter None; Mark Christopher None; Christopher Bowd None; Rui Fan None; Michael Goldbaum None; Akram Belghith None; Christopher Girkin National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Code F (Financial Support); Massimo Fazio F: National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Code F (Financial Support); Carlos DeMoraes Novartis, Galimedix, Belite, Reichert, Carl Zeiss, Perfuse Therapeutics, Code C (Consultant/Contractor), Ora Clinical, Code E (Employment), Heidelberg, Topcon, Code R (Recipient); Jeffrey Liebmann Alcon, Allergan, Bausch & Lomb, Carl Zeiss Meditec, Heidelberg Engineering, Reichert, Valeant Pharmaceuticals, Code C (Consultant/Contractor), Bausch & Lomb, Carl Zeiss Meditec, Heidelberg Engineering, National Eye Institute, Novartis, Optovue, Reichert Technologies, Research to Prevent Blindness, Code F (Financial Support); Robert Weinreb Abbvie, Aerie Pharmaceuticals, Allergan, Equinox, Eyenovia, Nicox, Topcon, Code C (Consultant/Contractor), Heidelberg Engineering, Carl Zeiss Meditec, Konan Medical, Optovue, Centervue, Bausch&Lomb, Topcon, Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Code P (Patent); Linda Zangwill Abbvie Inc. Digitial Diagnostics, Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc. , Code F (Financial Support), Zeiss Meditec, Code P (Patent)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2037 – A0478. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Justin Huynh, Benton Gabriel Chuter, Mark Christopher, Christopher Bowd, Rui Fan, Michael Henry Goldbaum, Akram Belghith, Christopher A Girkin, Massimo A. Fazio, Carlos G DeMoraes, Jeffrey M Liebmann, Robert N Weinreb, Linda Zangwill; Use of Generative Adversarial Network to Improve Glaucoma Gradability of Fundus Images. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2037 – A0478.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Low-quality retinal images may impair a clinician’s ability to detect glaucoma and preclude use of deep learning (DL) models for glaucoma identification. The study’s purpose is to assess whether ungradable images can be improved by use of a paired Generative Adversarial Network (GAN) DL model, to yield gradable images.

Methods : 3217 fundus photographs from the Diagnostic Innovations in Glaucoma Study (DIGS) and African Descent and Glaucoma Evaluation Study (ADAGES) datasets were organized into 10,000 image pairs, of one inherently low quality source image and one high quality target image from the same eye. Image quality was calculated by a previously developed quality assessment DL model trained by ground truth of expert graders. The image pairs were used to train a Pix2Pix based GAN to perform image to image translation from low to high quality. The GAN was trained for 30 cycles (epochs) using adam optimizer with learning rate 2e-4, with L1 and adversarial binary cross entropy loss functions.

Results : Generated images from the model had a mean L1 distance of 0.275 and cross entropy of 4.034 from the target high quality images. Generated images had an average brightness increase of 18.30% and contrast increase of 34.31% from the source low quality images, indicating that the GAN tends to increase the brightness and contrast of input images. Qualitatively, the GAN learns quickly, requiring one epoch to improve its output from random noise (fig 1a) to a blurry rendition of the optic nerve head (figure 1b). After 30 epochs, the GAN learns to produce images with clear retinal vasculature and detail that resembles the target images (fig 1c). The GAN seems to increase brightness and improve contrast of the optic nerve head and vasculature. In some examples, the GAN may insert vasculature into the image (fig 2b). Also, the GAN may insert cropping into the generated image, mimicking the cropping in the ground truth images (fig 2c).

Conclusions : GAN shows promise to improve human gradability of fundoscopic images in the detection of glaucoma. Further investigation must be done to explain unexpected output and assess glaucoma gradability of generated images.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Figure 1: GAN sample outputs for a single example before training (A), after one epoch of training (B) and after 30 epochs of training (C).

Figure 1: GAN sample outputs for a single example before training (A), after one epoch of training (B) and after 30 epochs of training (C).

 

Figure 2: GAN sample outputs from the final model trained for 30 epochs.

Figure 2: GAN sample outputs from the final model trained for 30 epochs.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×